'Clinical pharmacology' diaporamas de présentation

INTRODUCTION TO PHARMACOLOGY

INTRODUCTION TO PHARMACOLOGY. Pharmacist Jeanette Jasper Tenga (Mrs. J. Senkondo) 9 th of November 2016. Common ground for the task ahead. Why do you want to become a medical professional? What would you like to be? What do you think are going to be your responsibilities?

1.25k views • 65 slides

?????????????????????

1.05k views • 60 slides

Grapefruit Juice-Drug Interaction

Grapefruit Juice-Drug Interaction. Paul F. Cancalon. Florida Department of Citrus. http://www.wlap.org/wl-repository/umich/cacr/grand-rounds/20031202-annarbor-01-watkins/real/sld011.htm. P. B. Watkins 2003. Drug Taken with GJ. Drug Blood Concentration (AUC). Drug Taken without GJ. Time.

1.37k views • 59 slides

Sydney Cancer Institute

Sydney Cancer Institute. University of Sydney 19 th Jan 2004. Organisation and Research Direction. The Sydney Cancer Institute is an independent research institute established in February 2003 by: Sydney Cancer Centre The Central Sydney Area Heath Service (CSAHS) The University of Sydney

1.13k views • 58 slides

Francesco Scaglione, MD, PhD Department of Medical Biotechnology and Translational Medicine

721 views • 49 slides

Why should I lose time to send a report of adverse drug reactions?

Why should I lose time to send a report of adverse drug reactions?. The voluntary ADR reporting was developed to detect rare, serious, unexpected adverse drug, mainly type B, reactions over 40 years ago. . What is an adverse drug reaction?.

632 views • 43 slides

INTRODUCTION

INTRODUCTION. Depression afflicts approximately 5% of the population, 1-2% with bipolar disorder. Suicide from depression is 25-30% of depressed population. Depression 2-3 X higher in women. 70% of patients have response to drugs. There is major depression and secondary mood disorders.

1.14k views • 42 slides

INTRODUCTION TO PHARMACOLOGY

INTRODUCTION TO PHARMACOLOGY. Pharmacist Jeanette Jasper Tenga (Mrs. J. Senkondo) Nov 2011. Common ground for the task ahead. Why do you want to become a medical professional? What would you like to be?

933 views • 41 slides

Aromatase inhibitors in the era of Evidence Based Medicine dr. Vivianne Tjan-Heijnen UMC St Radboud NKI symposium 29 j

Aromatase inhibitors in the era of Evidence Based Medicine dr. Vivianne Tjan-Heijnen UMC St Radboud NKI symposium 29 juni 2005. Aromatase inhibitors in the era of Evidence Based Medicine. Evidence or believe That is the question. What does a patient expect when receiving a treatment?.

428 views • 29 slides

Electronic Medical Records as a Tool in Clinical Pharmacology: Opportunities and Challenges

Electronic Medical Records as a Tool in Clinical Pharmacology: Opportunities and Challenges. ??? ??? ? ? ?? ??? ? ? ? ? ?? 2014/05/19. Introduction. ???. Electronic Medical Records. EMR v.s . Traditional Medical Records Passive v.s . Active EMR Capabilities Preventive medical alerts

360 views • 25 slides

A Career in the Pharmaceutical Sciences

A Career in the Pharmaceutical Sciences. Unlimited Potential. Sponsored by the American Association of Pharmaceutical Scientists. What are the Pharmaceutical Sciences?.

711 views • 20 slides

The overview of metabolism

The overview of metabolism. Associate professor Shi-Jie Liu,Ph D. Department of clinical pharmacology, Xinqiao hospital, TMMU. An open system:Exchange mass and energy ?S surrounding +?S system >0, biology capture negative entropy from surrounding.

428 views • 18 slides

Drugs for the treatment of ED

Basic & Clinical Pharmacology. Drugs for the treatment of ED. Causes of ED. Cause: 1. psychological, 2. Physical injury, 3. Drug-induced, 4. Life-style, 5. Diseases, such as DM. Prevalence 10%. CMAJ 2004;170(9):1429-37. Anatomy of penis and its erection.

778 views • 16 slides

Academic OneFile

987 views • 14 slides

Risk Management: Practical Implications for Pharmaceutical Manufacturers

Risk Management: Practical Implications for Pharmaceutical Manufacturers. Mary Ellen Turner MD, MPH Vice-President Global Safety Surveillance & Epidemiology. April 11, 2005. The Bar is Being Raised Across the Industry for Formal Risk Management Planning.

354 views • 14 slides

A Career in Oncology

320 views • 14 slides

Drug Actions and Handling by the Body - Pharmacokinetics

Drug Actions and Handling by the Body - Pharmacokinetics. David Henry. Discipline of Clinical Pharmacology. Introduction: What we will cover . How do drugs act and how are they handled by the body? Drug Action, Drug Absorption, Drug Distribution and Drug Elimination

439 views • 13 slides

FDA Advisory Committee Pharmaceutical Sciences November 29, 2001

Individual Bioequivalence: Strengths and Weaknesses of the Current Approach: View from the Generic Pharmaceutical Association by MDS Pharma Services. Mario Tanguay, BPharm, PhD Associate Director, Pharmacokinetics. FDA Advisory Committee Pharmaceutical Sciences November 29, 2001.

254 views • 7 slides

clinical trial market, pharmceuticals market, market researc

Bharat Book Presents"Singapore Clinical Trial Market Opportunity Analysis". Singapore has off late come to become the nucleus of clinical research activities in the Asia-Pacific region. The country is a natural hub for manufacturers and clinicians.

198 views • 7 slides

CURRENT STATUS AND FUTURE PERSPECTIVES OF DRUG INFORMATION SYSTEMS

CURRENT STATUS AND FUTURE PERSPECTIVES OF DRUG INFORMATION SYSTEMS. T. Tervonen (1), V. Oskuee (1) , E.O. de Brock (1), P.A. de Graeff (2), H.L. Hillege (3) Faculty of Economics and Business, RUG.nl Department of Clinical Pharmacology & Internal Medicine, UMCG.nl

136 views • 1 slides